Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
View Patent ↗The intramuscular electroporated injection of a protease-resistant growth hormone-releasing hormone (“GHRH”) cDNA into rat dams at 16 days of gestation resulted in the enhanced long-term growth of the F1 offspring. The offspring were significantly heavier by one week of age and the difference was sustained to 10 weeks of age. Consistent with their augmented growth, plasma IGF-I concentration of the F1 progeny was increased significantly. The pituitary gland of the offspring was significantly heavier, and contained an increased number of somatotropes (cells producing GH) and lactotrophs (prolactin-secreting cells), and is indicative of an alteration in cell lineages. These unique findings demonstrate that enhanced GHRH expression in pregnant dams can result in intergenerational growth promotion, by altering development of the pituitary gland in the offspring.
1. A method of elevating prolactin levels in an offspring from a non-human female mammal comprising:
electroporating an effective amount of a nucleic acid expression construct into muscle cells of the non-human female mammal prior to or during gestation of the offspring, wherein the nucleic acid expression construct contains a nucleic acid sequence encoding a growth hormone releasing hormone (“GHRH”) in the non-human female mammal during gestation; and wherein the vector comprises a promoter; a nucleotide sequence encoding the GHRH; and a 3′ untranslated region, under conditions that promote expression of the nucleotide sequence, and wherein the introduction and expression of the nucleic acid expression construct results in elevating prolactin levels in said offspring.
2. The method of claim 1 , further comprising selecting a promoter that comprises a synthetic myogenic promoter.
3. The method of claim 1 , further comprising selecting the 3′ untranslated region to comprise a human growth hormone (“hGH”) 3′ untranslated region (SEQ ID NO:8).
4. The method of claim 1 , further comprising selecting the nucleic acid expression construct to be selected from group consisting of TI-GHRH plasmid (SEQ ID NO:12), TV-GHRH Plasmid (SEQ ID NO:13), 15/27/28 GHRH plasmid (SEQ ID NO:14), pSP-wt-GHRH plasmid (SEQ ID NO:15).
5. The method of claim 1 , further comprising mixing the nucleic acid expression construct with a transfection-facilitating polypeptide.
6. The method of claim 5 , further comprising selecting the transfection-facilitating polypeptide to comprise a charged polypeptide.
7. The method of claim 5 , further comprising selecting the transfection-facilitating polypeptide to comprise poly-L-glutamate.
8. The method of claim 1 , wherein the nucleic acid sequence encodes a growth-hormone-releasing-hormone (“GHRH”), and wherein the GHRH comprises an amino acid formula (SEQ ID NO:6):
-X 1 -X 2 -DAIFTNSYRKVL-X 3 -QLSARKLLQDI-X 4 -X 5 -RQQGERNQEQGA-OH
wherein the formula has the following characteristics:
X 1 is the amino acid tyrosine (“Y”), or histidine (“H”);
X 2 is the amino acid alanine (“A”), valine (“V”), or isoleucine (“I”);
X 3 is the amino acid alanine (“A”) or glycine (“G”);
X 4 is the amino acid methionine (“M”), or leucine (“L”);
X 5 is the amino acid serine (“S”) or asparagine (“N”).
9. The method of claim 1 , further comprising electroporating the nucleic acid expression construct into the non-human female mammal in multiple administrations.
10. The method of claim 1 , further comprising selecting the third trimester of gestation of the offspring for electroporating the nucleic acid expression construct into cells of the non-human female mammal.
11. A method of elevating prolactin levels in an offspring from a non-human female mammal comprising:
electroporating an effective amount of a nucleic acid expression construct into muscle cells of the non-human female mammal prior to or during gestation of the offspring, wherein the nucleic acid expression construct comprises SEQ ID NO: 11 and wherein the introduction and expression of the nucleic acid expression construct results in elevating prolactin levels in said offspring.
12. The method of claim 11 , further comprising mixing the nucleic acid expression construct with a transfection-facilitating polypeptide before electroporating.
13. The method of claim 12 , further comprising selecting the transfection-facilitating polypeptide to comprise a charged polypeptide.
14. The method of claim 12 , further comprising selecting the transfection-facilitating polypeptide to comprise poly-L-glutamate.
15. The method of claim 11 , further comprising electroporating the nucleic acid expression construct into the non-human female mammal in multiple administrations.
16. The method of claim 11 , further comprising selecting the third trimester of gestation of the offspring for electroporating the nucleic acid expression construct into cells of the non-human female mammal.